SEQUENT SCIENTIFIC LTD.
Smart Quotes
Trade Value (Rs. in Lacs) | 0.00 |
Dividend Yield(%) | 0.00 |
TTM EPS (Rs.) | -0.19 |
P/E Ratio | 0.00 |
Book Value (Rs.) | 42.81 |
Face Value (Rs.) | 2 |
MCap (Rs. in Mn) | 28759.68 |
Price/Earning (TTM) | 657.21 |
Price/Sales (TTM) | 16.13 |
Price/Book (MRQ) | 2.69 |
PAT Margin (%) | -2.70 |
ROCE (%) | -0.68 |
Management Info :
Kamal K Sharma - Chairman Rajaram Narayanan - Managing DirectorRegistered Office :
Address :
301, ' Dosti Pinnacle',3rd Floor, Plot No. E7,Road No. 22, Wagle Indl. Estate,
Thane,
Maharashtra-400604
Phone : 022 4111 4777
Email : investorrelations@sequent.in
Website : www.sequent.in
We wish to inform you that the Company has executed Deed of ass..
QTR Dec 23 | ANNUAL 23 | |
---|---|---|
Net Profit | 45.8 | -60.8000000000003 |
Gross Profit | 60.9 | -97.4600000000003 |
Operating Profit | 92.88 | 18.8199999999997 |
Net Sales | 422.05 | 2226.85 |
Abbott India (BSE)  26946.00 (0.74%) | M.Cap ( in Cr) 57258.37 |
Sanofi India (BSE)  8118.25 (2.06%) | M.Cap ( in Cr) 18696.83 |
Dr. Reddy's Lab (BSE)  6155.15 (1.78%) | M.Cap ( in Cr) 102679.14 |
Divi's Lab (BSE)  3436.75 (2.14%) | M.Cap ( in Cr) 91234.91 |
Glaxosmithkline Phar (BSE)  1943.10 (3.26%) | M.Cap ( in Cr) 32917.29 |
|
PROMOTERS | 52.79 % |
|
MUTUAL FUNDS/UTI | 5.02 % |
|
NON-INSTITUTION | 33.86 % |
|
FI/BANKS/INSURANCE | 0 % |
|
GOVERNMENT | 0 % |
|
FII | 0 % |
Scheme Name | Hold(%) |
---|---|
Quant Healthcare Fund-R... | 5.16 |
Quant Small Cap Fund(G) | 0.94 |
ITI Pharma & Healthcare... | 0.92 |
UTI Healthcare Fund-Reg... | 0.81 |
Motilal Oswal Nifty Mic... | 0.24 |
Motilal Oswal S&P BSE H... | 0.15 |